SYDNEY, Australia and MINNEAPOLIS, June 13, 2018 (GLOBE NEWSWIRE) -- Medibio Limited (ASX:MEB) (OTCQB:MDBIF), the world leader in objective measurement technology for mental health, has recently enhanced the compatibility of its mobile app product to accept data from Fitbit devices equipped with heart rate monitors.
About Medibio Limited
Medibio (ASX:MEB) (OTCQB:MDBIF) is a mental health technology company that has pioneered the use of objective biometrics to assist in the screening, diagnosing, monitoring and management of depression and other mental health conditions. The company offers mental health solutions for business through its Corporate Health programs and is developing products to serve both the consumer and regulated healthcare provider markets. The company was founded in Australia, with offices located in Perth (WA), and Minneapolis, MN (U.S.). Medibio is listed on the Australian Securities Exchange Ltd and trades on the OTCQB Venture Market. Investors can find additional information on www.otcmarkets.com and www.asx.com.au.Further Information: | Website: www.medibio.com.au |
Press Inquiries: Josh Purdy Medibio Limited josh.purdy@medibio.com.au T: 952-222-0551 ext. 204 M: 612-695-0168 | Australian Media Enquiries: Nicholas Hay RES Publica nhay@respublica.com.au T: +61 475 792 917 // +61 2 8297 1503 |
Copyright © 2024 - Todos os direitos reservados para o Grupo Estado.
As notícias e cotações deste site possuem delay de 15 minutos.